Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-05T10:25:18.566Z Has data issue: false hasContentIssue false

17 - Epidemiology of viral encephalitis

from Section III - Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses

Published online by Cambridge University Press:  22 August 2009

Nino Khetsuriani
Affiliation:
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Larry J. Anderson
Affiliation:
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Carol Shoshkes Reiss
Affiliation:
New York University
Get access

Summary

Introduction

The epidemiology of encephalitis is a composite of the epidemiologic features of the multiple individual etiologies associated with this syndrome. Understanding the epidemiology is confounded by difficulties in both clearly defining a case and determining its etiology. Encephalitis, or inflammation of brain tissue, can occur from various insults to the central nervous system (CNS) including direct invasion by an infectious agent; an abnormal immune response to infection, vaccines, or antigens present at sites outside the CNS; or a combination of factors. In addition, the symptoms of brain dysfunction, the clinical hallmark of encephalitis, can also be associated with a number of noninfectious entities including autoimmune diseases, tumors, paraneoplastic syndromes, metabolic disorders, and toxins.

The many causes of encephalitis and nonencephalitic brain disease, the fact that the many different causes often cannot be distinguished clinically, and the difficulty in defining its etiology have frustrated our understanding of this syndrome. Encephalitis is, however, associated with substantial morbidity, long-term disability, and death and, consequently, is an important problem for which better treatment and prevention strategies could be of substantial benefit. This chapter will focus on overall epidemiologic patterns. Information on specific agents can be found in more detail in the virus-specific sections.

Definitions

Various case definitions of encephalitis in general and for encephalitides due to specific etiologies such as smallpox vaccination, arbovirus infections, and rabies infection, have been developed [1, 2, 3, 4]. These definitions include clinical signs and symptoms that indicate involvement of the parenchyma of the brain (e.g. altered consciousness, personality changes, focal neurologic findings such as weakness or paralysis, and seizures) and results of laboratory studies (e.g., examination of cerebral spinal fluid [CSF]), brain imaging, and/or electroencephalography (EEG) studies that suggest brain disease and inflammation.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control, Morbidity and Mortality Weekly Report. Recommendations and Reports, 39 (1990) 1–43.
Centers for Disease Control, Morbidity and Mortality Weekly Report. Recommendations and Reports, 46 (1997) 1–55.
Glaser, C. A., Gilliam, S., Schnurr, D., et al., Clin Infect Dis, 36 (2003) 731–42.CrossRef
Kolski, H., Ford-Jones, E. L., Richardson, S., et al., Clin Infect Dis, 26 (1998) 398–409.CrossRef
Glaser, C. A., Honarmand, S., Anderson, L. J., et al., Clin Infect Dis, 43 (2006) 1565–77.CrossRef
Sivertsen, B. and Christensen, P. B., Acta Neurol Scand, 93 (1996) 156–9.CrossRef
Rantalaiho, T., Färkkilä, M., Vaheri, A., et al., J Neurol Sci, 184 (2001) 169–77.CrossRef
Iff, T., Donati, F., Vassella, F., et al., Eur J Paediatr Neurol, 2 (1998) 233–7.CrossRef
Studahl, M., Bergström, T., and Hagberg, L., Scand J Infect Dis, 30 (1998) 215–20.
Khetsuriani, N., Holman, R. C., and Anderson, L. J., Clin Infect Dis, 35 (2002) 175–82.CrossRef
Lee, T. C., Tsai, C. P., Yuan, C. L., et al., J Infect Dis, 56 (2003) 193–9.
Koskiniemi, M., Korppi, M., Mustonen, K., et al., Eur J Pediatr, 156 (1997) 541–5.CrossRef
Koskiniemi, M., Rautonen, J., Lehtokoski-Lehtiniemi, E., et al., Ann Neurol, 29 (1991) 492–7.CrossRef
Kupila, L., Vuorinen, T., Vainionpää, R., et al., Neurology, 66 (2006) 75–80.CrossRef
Srey, V. H., Sadones, H., Ong, S., et al., Am J Trop Med Hyg, 66 (2002) 200–7.CrossRef
Khetsuriani, N., Holman, R. C., Lamonte-Fowlkes, A. C., et al., Epidemiol Infect, 135 (2007) 583–91.CrossRef
Davison, K. L., Crowcroft, N. S., Ramsay, M. E., et al., Emerg Infect Dis, 9 (2003) 234–40.CrossRef
Xu, Y., Zhaori, G., Vene, S., et al., Pediatr Infect Dis J, 15 (1996) 1018–24.CrossRef
Dubberke, E. R., Tu, B., Rivet, D.J., et al., J Neurovirol, 12 (2006) 235–40.CrossRef
West, T. E., Papasian, C. J., Park, B. H., et al., Arch Neurol, 42 (1985) 815–7.CrossRef
Sutton, R. N., Pullen, H. J., Blackledge, P., et al., Lancet, 2 (1976) 987–91.CrossRef
Slatter, M. A., Read, S., Taylor, C. E., et al., J Clin Microbiol, 43 (2005) 1462–4.CrossRef
Gregg, M. B., Bull World Health Organ, 52 (1975) 549–53.
Vreede, R. W., Schellekens, H., and Zuijderwijk, M., J Infect Dis, 165 (1992) 1166.CrossRef
Isaia, G., Teodosiu, O., Popescu, G., et al., Virology, 31 (1980) 191–5.
Eash, S., Manley, K., Gasparovic, M., et al., Cell Mol Life Sci, 63 (2006) 865–76.CrossRef
Maschke, M., Kastrup, O., and Diener, H. C., CNS Drugs, 16 (2002) 303–15.CrossRef
Doja, A., Bitnun, A., Jones, E. L., et al., J Child Neurol, 21 (2006) 385–91.CrossRef
Ward, K. N., Curr Opin Infect Dis, 18 (2005) 247–52.CrossRef
Ansari, A., Li, S., Abzug, M. J., et al., Emerg Infect Dis, 10 (2004) 1450–4.CrossRef
Lahat, E., Barr, J., Barkai, G., et al., Arch Dis Child, 80 (1999) 69–71.CrossRef
Weitkamp, J. H., Spring, M. D., Brogan, T., et al., Pediatr Infect Dis J, 23 (2004) 259–63.CrossRef
Togashi, T., Matsuzono, Y., Narita, M., et al., Virus Res, 103 (2004) 75–8.CrossRef
Lynch, M., Lee, B., Azimi, P., et al., Clin Infect Dis, 33 (2001) 932–8.CrossRef
Ng, Y. T., Cox, C., Atkins, J., et al., J Child Neurol, 16 (2001) 105–8.CrossRef
Sweetman, L. L., Ng, Y. T., Butler, I. J. I., et al., Pediatr Neurol, 32 (2005) 307–10.CrossRef
Barah, F., Vallely, P. J., Chiswick, M. L., et al., Lancet, 358 (2001) 729–30.CrossRef
Tonnellier, M., Bessereau, J., Carbonnell, N., et al., J Clin Virol, 38 (2007) 186–7.CrossRef
Chadha, M. S., Arankalle, V. A., Jadi, R. S., et al., Am J Trop Med Hyg, 73 (2005) 566–70.
Sejvar, J. J., Curr Opin Neurol, 19 (2006) 350–7.CrossRef
Weinberg, A., Bloch, K. C., Li, S., et al., J Infect Dis, 191 (2005) 234–7.CrossRef
Tang, Y. W., Espy, M. J., Persing, D. H., et al., J Clin Microbiol, 35 (1997) 2869–72.
Arlazoroff, A., Bleicher, Z., Klein, C., et al., Acta Neurol Scand, 76 (1987) 210–14.CrossRef
Prevots, D. R., Burr, R. K., Sutter, R. W., et al., MMWR Recomm Rep, 49 (2000) 1–22.
Alexander, L. N., Seward, J. F., Santibanez, T. A., et al., JAMA, 292 (2004) 1696–701.CrossRef
Cetron, M. S., Marfin, A. A., Julian, K. G., et al., MMWR Recomm Rep, 51 (2002) 1–11.
Plotkin, S. A., Rupprecht, C. E., and Koprowski, H. In Plotkin, S. A., and Orenstein, W. A. (Eds.), Vaccines, Saunders, Philadelphia, 1999, pp.743–66.
Henderson, D. A. and Moss, B. In Plotkin, S. A. and Orenstein, W. A. (Eds.), Vaccines, Saunders, Philadelphia, 1999, pp.74–97.Google ScholarPubMed
Piyasirisilp, S. and Hemachudha, T., Curr Opin Neurol, 15 (2002) 333–8.CrossRef
Chokephaibulkit, K., Kankirawatana, P., Apintanapong, S., et al., Pediatr Infect Dis J, 20 (2001) 216–18.CrossRef
Sejvar, J. J. and Marfin, A. A., Rev Med Vir, 16 (2006) 209–24.CrossRef
Roos, K. L., Neurol Clin, 17 (1999) 813–33.CrossRef
Skoldenberg, B., Scand J Infect Dis (Suppl 100) (1996) 8–13.
Mackenzie, J. S., J Neurovirol, 11 (2005) 434–40.CrossRef
Paweska, J. T., Blumberg, L. H., Liebenberg, C., et al., Emerg Infect Dis, 12 (2006) 1965–7.CrossRef
Bellini, W. J., Harcourt, B. H., Bowden, N., et al., J Neurovirol, 11 (2005) 481–7.CrossRef
Beghi, E., Nicolosi, A., Kurland, L. T., et al., Ann Neurol, 16 (1984) 283–94.CrossRef
Rantala, H. and Uhari, M., Pediatr Infect Dis J, 8 (1989) 426–30.CrossRef
Kamei, S. and Takasu, T., Intern Med, 39 (2000) 894–900.CrossRef
Najioullah, F., Bosshard, S., Thouvenot, D., et al., J Med Virol, 61 (2000) 468–73.3.0.CO;2-9>CrossRef
Raschilas, F., Wolff, M., Delatour, F., et al., Clin Infect Dis, 35 (2002) 254–60.CrossRef
Patnaik, J. L., Harmon, H., and Vogt, R. L., Emerg Infect Dis, 12 (2006) 1129–31.CrossRef
Klee, A. L., Maidin, B., Edwin, B., et al., Emerg Infect Dis, 10 (2004) 1405–11.CrossRef
Zohrabian, A., Meltzer, M. I., Ratard, R., et al., Emerg Infect Dis, 10 (2004) 1736–44.CrossRef
Büttner, T. and Dorndorf, W., Fortschr Neurol Psychiatr, 56 (1988) 315–25.CrossRef
Miller, J. D. and Ross, C. A., Lancet, 1 (1968) 1121–6.CrossRef
Green, M. S., Weinberger, M., Ben-Ezer, J., et al., Emerg Infect Dis, 11 (2005) 1754–7.CrossRef
Knobel, D. L., Cleaveland, S., Coleman, P. G., et al., Bull World Health Organ, 83 (2005) 360–8.
WHO, Japanese encephalitis vaccines, Wkly Epidemiol Rec, 81 (2006) 331–40.
Solomon, T., Dung, N. M., Kneen, R., et al., J Neurol, Neurosurgery and Psychiatry, 68 (2000) 405–15.CrossRef
Haaland, K. Y., Sadek, J., Pergam, S., et al., Emerg Infect Dis, 12 (2006) 1260–2.CrossRef
Murray, K. O., Resnick, M., and Miller, V., Emerg Infect Dis, 13 (2007) 479–81.CrossRef
Rantala, H., Uhari, M., Uhari, M., et al., Dev Med Child Neurol, 33 (1991) 858–67.CrossRef
Chang, L. Y., Huang, L. M., Gau, S. S., et al., N Engl J Med, 356 (2007) 1226–34.CrossRef
McKinney, R. E., Katz, S. L., and Wilfert, C. M., Rev Infect Dis, 9 (1987) 334–56.CrossRef
Kumar, D., Prasad, G. V., Zaltzman, J., et al., Transplantation, 77 (2004) 399–402.CrossRef
Mamidi, A., DeSimone, J. A., and Pomerantz, R. J., J Neurovirol, 8 (2002) 158–67.CrossRef
Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., et al., Neurology, 42 (1992) 1472–6.CrossRef
Lam, K. and Chua, K., Clin Infect Dis, 34 (2002) S48–S51CrossRef
Parashar, U. D., Sunn, L. M., Ong, F., et al., J Infect Dis, 181 (2000) 1755–9.CrossRef
Chadha, M. S., Comer, J. A., Lowe, L., et al., Emerg Infect Dis, 12 (2006) 235–40.CrossRef
WHO, Wkly Epidemiol Rec, 77 (2002) 297–9.
Tsai, T. F., Infect Dis Clin North Am, 5 (1991) 73–102.
Nathanson, N. and Martin, J. R., Am J Epidemiol, 110 (1979) 672–92.CrossRef
Whitley, R. J., N E J Med, 323 (1990) 242–50.CrossRef
Modlin, J. F., Adv Pediatr Infect Dis, 12 (1996) 155–80.
LaMonte, A., Honarmand, S., Glaser, C., et al., Abstracts of the 43rd Annual Meeting of IDSA, San Francisco, CA, October 6–9, 2005, 207.Google Scholar
Lowry, P. W., Truong, D. H., Hinh, L. D., et al., Am J Trop Med Hyg, 58 (1998) 324–9.CrossRef
Morishima, T., Togashi, T., Yokota, S., et al., Clin Infect Dis, 35 (2002) 512–17.CrossRef
Anderson, L. J., Nicholson, K. G., Tauxe, R. V., et al., Ann Intern Med, 100 (1984) 728–35.CrossRef
Noah, D. L., Drenzek, C. L., Smith, J. S., et al., Ann Intern Med, 128 (1998) 922–30.CrossRef
Hill, A., Annu Rev Genet, 40 (2006) 469–86CrossRef
Tuite, A. and Gros, P., Microbes Infect, 8 (2006) 1647–53.CrossRef
Glass, W. G., McDermott, D. H., Lim, J. K., et al., J Exp Med, 203 (2006) 35–40.CrossRef
Diamond, M. S. and Klein, R. S., Trends Microbiol, 14 (2006) 287–9.CrossRef
Lim, J. K., Glass, W. G., McDermott, D. H., et al., Trends Immunol, 27 (2006) 308–12.CrossRef
Seligman, S. J., J Infect Dis, 193 (2006) 1187–8; author reply 1188.CrossRef
Yakub, I. I., Lillibridge, K. M., Moran, A., et al., J Infect Dis, 192 (2005) 1741–8.CrossRef
Hidaka, F., Matsuo, S., Muta, T., et al., Clin Immunol, 119 (2006) 188–94.CrossRef
Mullins, J. A., Khetsuriani, N., Nix, W. A., et al., Clin Infect Dis, 38 (2004) 70–7.CrossRef
Oberste, M. S., Maher, K., Kennett, M. L., et al., J Clin Microbiol, 37 (1999) 3928–33.
Savolainen, C., Hovi, T., and Mulders, M. N., Arch Virol, 146 (2001) 521–37.CrossRef
Liu, W. J., Wang, X. J., Clark, D. C., et al., J Virol, 80 (2006) 2396–404.CrossRef
Kung, C. M., King, C. C., Lee, C. N., et al., J Med Virol, 79 (2007) 60–8.CrossRef
Evans, D. M., Dunn, G., Minor, P. D., et al., Nature, 314 (1985) 548–50.CrossRef
Cann, A. J., Stanway, G., Hughes, P. J., et al., Nucleic Acids Res, 12 (1984) 7787–92.CrossRef
Kew, O., Morris-Glasgow, V., Landaverde, M., et al., Science, 296 (2002) 356–9.CrossRef
Xu, F., Sternberg, M. R., Kottiri, B. J., et al., JAMA, 296 (2006) 964–73.CrossRef
Hammer, S. M., Buchman, T. G., Angelo, L. J., et al., J Infect Dis, 141 (1980) 436–40.CrossRef
Landry, M. L., Berkovits, N., Summers, W. P., et al., Neurology, 33 (1983) 831–5.CrossRef
Hayes, E. B., Komar, N., Nasci, R. S., et al., Emerg Infect Dis, 11 (2005) 1167–73.CrossRef
Lowry, P. W., J Lab Clin Med, 129 (1997) 405–11.CrossRef
Khetsuriani, N., Lamonte-Fowlkes, A., Oberst, S., et al., MMWR CDC Surveill Summ, 55 (2006) 1–20.
Khetsuriani, N., Quiroz, E. S., Holman, R. C., et al., Neuroepidemiology, 22 (2003) 345–52.CrossRef
Koskiniemi, M., Rantalaiho, T., Piiparinen, H., et al., J Neurovirol, 7 (2001) 400–8.CrossRef
Peck, A. J., Supawat, K., Liamsuwan, S., et al., Etiology of Encephalitis in Thailand, Abstracts of the 43rd Annual Meeting of IDSA, San Francisco, CA, October 6–9, 2005, p. 51.Google Scholar
Ishikawa, T., Asano, Y., Morishima, T., et al., Brain Dev, 15 (1993) 192–7.CrossRef
Huang, C., Morse, D., Slater, B., et al., Clin Infect Dis, 39 (2004) 630–5.CrossRef
Günther, G. and Haglund, M., CNS Drugs, 19 (2005) 1009–32.CrossRef
Mickiene, A., Laiskonis, A., Günther, G., et al., Clin Infect Dis, 35 (2002) 650–8.CrossRef
Ravi, V., Indian J Med Microbiol, 24 (2006) 83–4.CrossRef
Kumarasamy, V., Prathapa, S., ZURidah, H., et al., Med J Malaysia, 61 (2006) 221–5.
Josseran, L., Paquet, C., Zehgnoun, A., et al., Emerg Infect Dis, 12 (2006) 1994–5.CrossRef
Hanna, N., Carney, K., Smith, G. A., et al., Med J Aust, 172 (2000) 597–9.
Ooi, M. H., Wong, S. C., Podin, Y., et al., Clin Infect Dis, 44 (2007) 646–56.CrossRef
Ho, M., Chen, E. R., Hsu, K. H., et al., N Engl J Med, 341 (1999) 929–35.CrossRef
Lin, T. Y., Twu, S. J., Ho, M. S., et al., Emerg Infect Dis, 9 (2003) 291–3.CrossRef
Chong, C. Y., Chan, K. P., Shah, V. A., et al., Acta Paediatr, 92 (2003) 1163–9.CrossRef
Gilbert, G. L., Dickson, K. E., Waters, M. J., et al., Pediatr Infect Dis J, 7 (1988) 484–8.CrossRef
Ho, M., J Microbiol Immunol Infect, 33 (2000) 205–16.
Shepherd, J. C., Subramanian, A., Montgomery, R. A., et al., Am J Transplant, 4 (2004) 830–3.CrossRef
Fischer, S. A., Graham, M. B., Kuehnert, M. J., et al., N Engl J Med, 354 (2006) 2235–49.CrossRef
Srinivasan, A., Burton, E. C., Kuehnert, M. J., et al., N Engl J Med, 352 (2005) 1103–11.CrossRef
Iwamoto, M., Jernigan, D. B., Guasch, A., et al., N Engl J Med, 348 (2003) 2196–203.CrossRef
Pealer, L. N., Marfin, A. A., Petersen, L. R., et al., N Engl J Med, 349 (2003) 1236–45.CrossRef
Nash, D., Mostashari, F., Fine, A., et al., N Engl J Med, 344 (2001) 1807–14.CrossRef
Hayes, E. B. and Gubler, D. J., Annu Rev Med, 57 (2006) 181–94.CrossRef
CDC, Arboviral encephalitis cases reported in humans, by type, United States, 1964–2005; http://www.cdc.gov/ncidod/dvbid/arbor/arbocase.htm?. Accessed June 3, 2007.
CDC, MMWR Morb Mortal Wkly Rep, 44 (1996) 1–87.
CDC, MMWR Morb Mortal Wkly Rep, 50 (2001) 761–4.
Calisher, C. H., Clin Microbiol Rev, 7 (1994) 89–116.CrossRef
McNabb, S. J., Jajosky, R. A., Hall-Baker, P. A., et al., MMWR Morb Mortal Wkly Rep, 54 (2007) 1–92.
CDC, MMWR Morb Mortal Wkly Rep, 47 (1998) 517–22.
Huang, C., Campbell, W., Grady, L., et al., Clin Infect Dis, 28 (1999) 1294–7.CrossRef
Tsai, T. F., Popovici, F., Cernescu, C., et al., Lancet, 352 (1998) 767–71.CrossRef
Platonov, A. E., Shipulin, G. A., Shipulina, O. Y., et al., Emerg Infect Dis, 7 (2001) 128–32.CrossRef
Charrel, R. N., Gallian, P., Navarro-Mari, J. M., et al., Emerg Infect Dis, 11 (2005) 1657–63.CrossRef
Treeck, U., Euro Surveill, 11 (2006) E060511.060511–E060511.060511.
Gajanana, A., Thenmozhi, V., Samuel, P. P., et al., Bull World Health Organ, 73 (1995) 237–44.
Kumar, R., Mathur, A., Kumar, A., et al., Arch Dis Child, 65 (1990) 1227–30.CrossRef
Weinberger, M., Pitlik, S. D., Gandacu, D., et al., Emerg Infect Dis, 7 (2001) 686–91.CrossRef
Misra, U. K., Kalita, J., Syam, U. K., et al., J Neurol Sci, 244 (2006) 117–22.CrossRef
Al-Hazmi, M., Ayoola, E. A., Abdurahman, M., et al., Clin Infect Dis, 36 (2003) 245–52.CrossRef
Alrajhi, A. A., Al-Semari, A., and Al-Watban, J., Emerg Infect Dis, 10 (2004) 554–5.CrossRef
Liu, C., Johansen, C., Kurucz, N., et al., Commun Dis Intell, 30 (2006) 411–29.
Eaton, B. T., Broder, C. C., Middleton, D., et al., Microbiology, 4 (2006) 23–35.
O'Sullivan, J. D., Allworth, A. M., Paterson, D. L., et al., Lancet, 349 (1997) 93–5.CrossRef
Allworth, A., Murray, K., and Morgan, J., Commun Dis Intell, 20 (1996) 504.
Diaz, L. A., , V., Almirón, W. R., et al., Emerg Infect Dis, 12 (2006) 1752–4.CrossRef
Depoortere, E., Kavle, J., Keus, K., et al., Trop Med Int Health, 9 (2004) 730–6.CrossRef
Feki, I. I., Marrakchi, C., Ben Hmida, M., et al., Neuroepidemiology, 24 (2005) 1–7.CrossRef
CDC, MMWR Morb Mortal Wkly Rep, 56 (2007) 278–81.
CDC, MMWR Morb Mortal Wkly Rep, 55 (2006) 1198–201.
Bell, J. E., Lowrie, S., Koffi, K., et al., J Neuropathol Exp Neurol, 56 (1997) 686–92.CrossRef
Wilde, H., Khawplod, P., Khamoltham, T., et al., Vaccine, 23 (2005) 2284–9.CrossRef
Rautonen, J., Koskiniemi, M., and Vaheri, A., Pediatr Infect Dis J, 10 (1991) 441–6.CrossRef
Hokkanen, L. and Launes, J., Neuropsychol Rev, 10 (2000) 151–67.CrossRef
Tenembaum, S., Chamoles, N., and Fejerman, N., Neurology, 59 (2002) 1224–31.CrossRef
Pepperell, C., Rau, N., Krajden, S., et al., CMAJ, 168 (2003) 1399–405.
Schneider-Schaulies, J., Meulen, V., and Schneider-Schaulies, S., J Neurovirol, 9 (2003) 247–52.CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Epidemiology of viral encephalitis
    • By Nino Khetsuriani, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, Larry J. Anderson, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.022
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Epidemiology of viral encephalitis
    • By Nino Khetsuriani, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, Larry J. Anderson, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.022
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Epidemiology of viral encephalitis
    • By Nino Khetsuriani, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, Larry J. Anderson, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.022
Available formats
×